Industry
Powering clinical research innovation: How TriNetX uses Databricks to accelerate drug development
TriNetX is a global health research network that connects pharmaceutical companies, study sites, investigators, and patients by leveraging real-world data (RWD) from electronic health records acros...
TriNetX is a global health research network that connects pharmaceutical companies, study sites, investigators, and patients by leveraging real-world data (RWD) from electronic health records across 170+ healthcare organizations to accelerate clinical trial design and drug development. By partnering with Databricks, TriNetX unifies rich clinical data in a research-ready environment, enabling researchers to accelerate time-to-insight through advanced analytics, AI, and machine learning — including cohort identification, protocol optimization, and patient recruitment. Together, the platforms support end-to-end drug development workflows, from trial feasibility and site selection to evidence generation, helping reduce costs and timelines in bringing new therapies to patients.
Related
- How Zalando built a unified data foundation for AI and analytics on Databricks
- Clinical trial shows gene editing works for β-Thalassaemia, too
- Californians sue over AI tool that records doctor visits
- Trump admin makes sweeping request for medical records of federal workers
Source: industry